Burstable Editorial Team

Burstable Editorial Team

NewsRamp Burstable Feed

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.

21769 articles
Maximize your thought leadership

Articles

VERAXA Biotech Presents Early Proof-of-Concept Data for BiTAC-ADC Platform, Showcasing Selective Cancer Cell Targeting

VERAXA Biotech Presents Early Proof-of-Concept Data for BiTAC-ADC Platform, Showcasing Selective Cancer Cell Targeting

VERAXA Biotech AG (NASDAQ: VRXA) announced new in vitro data demonstrating its BiTAC-ADC technology selectively destroys cancer cells while sparing healthy cells, as it prepares to seek partnerships at the BIO International Convention 2026.
Greenland Energy Advances Jameson Land Basin Toward 2026 Drilling Campaign

Greenland Energy Advances Jameson Land Basin Toward 2026 Drilling Campaign

Greenland Energy Company (NASDAQ: GLND) is progressing its Jameson Land Basin project in East Greenland, targeting first exploration drilling in October 2026, with potential resources of up to 13 billion barrels that could enhance energy security and drive economic development in Greenland.
Cancer Nanomedicine Advances as Onco-Innovations Moves Toward Clinical Trials with PNKP Inhibitor

Cancer Nanomedicine Advances as Onco-Innovations Moves Toward Clinical Trials with PNKP Inhibitor

Onco-Innovations is advancing its lead drug candidate ONC010, a PNKP inhibitor with a polymer nanodelivery system, as the field of cancer nanomedicine matures with over 20 approved formulations now improving patient outcomes.
Scientists Identify Molecular Pathway That Could Block Brain Metastases, Offering New Hope for Cancer Treatment

Scientists Identify Molecular Pathway That Could Block Brain Metastases, Offering New Hope for Cancer Treatment

Researchers from King’s College London and McMaster University have discovered a molecular pathway critical to cancer's ability to spread to the brain, potentially revolutionizing treatment for metastatic disease.
Precious Metal Prices Surge as Four Key Forces Drive Rally in Gold and Silver

Precious Metal Prices Surge as Four Key Forces Drive Rally in Gold and Silver

Gold and silver prices have rallied significantly, with gold reaching $4,362 per ounce and silver hitting $71.2 per ounce, driven by four key forces that could impact investors and the mining industry.
Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Emerging Oncology Market

Next-Generation DNA Repair Inhibitors Poised to Capture Billions in Emerging Oncology Market

DNA Damage Response inhibitors, led by Onco-Innovations' ONC010, represent a multi-billion dollar opportunity in the expanding oncology market, projected to reach $750 billion by 2030.
Quantum BioPharma Advances Novel MS Treatment Targeting Myelin Repair

Quantum BioPharma Advances Novel MS Treatment Targeting Myelin Repair

Quantum BioPharma is developing Lucid-MS, a first-in-class drug candidate that directly targets myelin sheath repair, aiming to halt multiple sclerosis progression where existing therapies only slow it down.
Study Warns Overreliance on AI May Undermine Critical Thinking Skills

Study Warns Overreliance on AI May Undermine Critical Thinking Skills

A new study suggests that excessive dependence on AI tools like ChatGPT and Claude can compromise critical thinking and independent judgment, with implications for industries such as gaming and beyond.
Functional Drinks Transition From Niche Trend to Everyday Wellness Staple

Functional Drinks Transition From Niche Trend to Everyday Wellness Staple

Functional beverages are moving beyond specialty stores into daily routines as consumers prioritize clean ingredients, convenience, and integration of hydration with nutrition.
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma is progressing its drug candidate Lucid-MS, a novel nonimmunomodulatory compound that directly protects myelin, into phase 2 clinical trials after filing an IND application with the FDA and completing phase 1 safety studies.
Beeline Holdings Joins Russell Microcap Index as AI-Driven Mortgage Platform Gains Traction

Beeline Holdings Joins Russell Microcap Index as AI-Driven Mortgage Platform Gains Traction

Beeline Holdings Inc. (NASDAQ: BLNE) has been added to the Russell Microcap Index effective June 29, reflecting its growth in digital mortgage lending with AI underwriting and a focus on gig-economy borrowers.
Onco-Innovations Advances Novel DNA Damage Response Cancer Therapy with ONC010

Onco-Innovations Advances Novel DNA Damage Response Cancer Therapy with ONC010

Onco-Innovations Limited is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for DNA Damage Response-targeted cancer therapies, with preclinical success and strategic partnerships advancing toward clinical trials.
Cardio Diagnostics Expands Access to Precision Cardiovascular Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Expands Access to Precision Cardiovascular Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Holdings secures coverage for its AI-powered blood tests through Atlas Healthcare Physicians, broadening access to noninvasive coronary heart disease risk assessment and diagnosis for managed care populations in Southern California.
Squeeze-Bottle Tahini Capitalizes on Consumer Demand for Simplicity in Pantry Staples

Squeeze-Bottle Tahini Capitalizes on Consumer Demand for Simplicity in Pantry Staples

Mighty Sesame Co.'s ready-to-use squeeze-bottle tahini reflects shifting consumer preferences toward convenient, versatile, single-ingredient plant-based foods that fit easily into daily cooking routines.
Massimo Group Terminates FST Acquisition to Focus on Internal Security Tech Development

Massimo Group Terminates FST Acquisition to Focus on Internal Security Tech Development

Massimo Group (NASDAQ: MAMO) has terminated its proposed acquisition of FST Development Company Limited, citing recent advancements in its internal security technology programs and a $4 million funding commitment from its controlling shareholder to accelerate development of intelligent patrol systems, autonomous vehicles, d...
Gaxos.ai Sells Gaming Assets for $1.76 Million to Focus on AI Growth

Gaxos.ai Sells Gaming Assets for $1.76 Million to Focus on AI Growth

Gaxos.ai divests its gaming portfolio to Game Foundry AI in a stock deal worth $1.76 million, aiming to concentrate resources on its higher-margin AI businesses.
HH Red Stone's Resident-First Philosophy Challenges Industry Norms in Student Housing Management

HH Red Stone's Resident-First Philosophy Challenges Industry Norms in Student Housing Management

HH Red Stone emphasizes treating student housing residents as CEOs to maintain urgency, reputation, and financial performance, a strategy that requires disciplined hiring and scaling to avoid common pitfalls in property management.
Rail Vision Completes ShuntingYard Field Testing with Israel Railways, Advancing Commercialization

Rail Vision Completes ShuntingYard Field Testing with Israel Railways, Advancing Commercialization

Rail Vision successfully tested its AI-powered ShuntingYard system with Israel Railways, leading to commercialization discussions and expanding potential reach through a partnership with Railserve.
Ladybug Resource Group's Jingdiao Division Expands Alliance with Mino to Support EV Production Lines

Ladybug Resource Group's Jingdiao Division Expands Alliance with Mino to Support EV Production Lines

Ladybug Resource Group's Jingdiao division deepens its strategic collaboration with global automation leader Mino, supplying precision components for next-generation electric vehicle manufacturing systems serving major automakers like Tesla, Volkswagen, and BMW.
Onco-Innovations Engages Nanosoft Polymers to Advance ONC010 Nanoparticle Cancer Therapy

Onco-Innovations Engages Nanosoft Polymers to Advance ONC010 Nanoparticle Cancer Therapy

Onco-Innovations Limited partners with Nanosoft Polymers to develop scalable manufacturing processes for its lead nanoparticle-formulated PNKP inhibitor, ONC010, moving toward clinical trials.
Helus Pharma Prices $50 Million Public Offering to Advance Psychedelic-Inspired Depression and Anxiety Treatments

Helus Pharma Prices $50 Million Public Offering to Advance Psychedelic-Inspired Depression and Anxiety Treatments

Helus Pharma announced the pricing of a $50 million public offering to fund Phase 3 trials for its major depressive disorder treatment and other programs, highlighting continued investment in novel serotonergic agonists for mental health.

Showing 2731-2751 of 21769 articles (Page 131 of 1037)